These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 3924113)
1. Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes. Smith JB; Dangelmaier C; Mauco G Biochim Biophys Acta; 1985 Jul; 835(2):344-51. PubMed ID: 3924113 [TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced transfer of arachidonic acid in human platelets is not inhibited by trifluoperazine. Mahadevappa VG Biochem Biophys Res Commun; 1987 Apr; 144(2):821-8. PubMed ID: 3107560 [TBL] [Abstract][Full Text] [Related]
4. The influence of some 3-amino-2-pyrazoline derivatives on cyclooxygenase and lipoxidase activities. Robak J; Duniec Z Biochem Pharmacol; 1982 Jun; 31(11):1955-9. PubMed ID: 6810898 [TBL] [Abstract][Full Text] [Related]
5. Effect of AA-861, a 5-lipoxygenase inhibitor, on leukotriene synthesis in human polymorphonuclear leukocytes and on cyclooxygenase and 12-lipoxygenase activities in human platelets. Mita H; Yui Y; Shida T Allergy; 1986 Sep; 41(7):493-8. PubMed ID: 3024521 [TBL] [Abstract][Full Text] [Related]
6. Evidence of Ca2+ mobilizing action of arachidonic acid in human platelets. Tohmatsu T; Nakashima S; Nozawa Y Biochim Biophys Acta; 1989 Jun; 1012(1):97-102. PubMed ID: 2499358 [TBL] [Abstract][Full Text] [Related]
7. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets: comparison with indomethacin and ETYA. Van Wauwe J; Goossens J Prostaglandins; 1983 Nov; 26(5):725-30. PubMed ID: 6422509 [TBL] [Abstract][Full Text] [Related]
8. Effects of fatty acyl coenzyme A esters on lipoxygenase and cyclooxygenase metabolism of arachidonic acid in rabbit platelets. Fujimoto Y; Tsunomori M; Sumiya T; Nishida H; Sakuma S; Fujita T Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):255-8. PubMed ID: 7784474 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of steroid production in Leydig cells by non-steroidal anti-inflammatory and related compounds: evidence for the involvement of lipoxygenase products in steroidogenesis. Dix CJ; Habberfield AD; Sullivan MH; Cooke BA Biochem J; 1984 Apr; 219(2):529-37. PubMed ID: 6430271 [TBL] [Abstract][Full Text] [Related]
10. A unique pool of free arachidonate serves as substrate for both cyclooxygenase and lipoxygenase in platelets. Chevy F; Wolf C; Colard O Lipids; 1991 Dec; 26(12):1080-5. PubMed ID: 1819690 [TBL] [Abstract][Full Text] [Related]
11. Neomycin is a potent agent for arachidonic acid release in human platelets. Nakashima S; Tohmatsu T; Shirato L; Takenaka A; Nozawa Y Biochem Biophys Res Commun; 1987 Jul; 146(2):820-6. PubMed ID: 3113426 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the lipoxygenase arachidonic acid pathway impair glycocholate efflux in isolated rat hepatocytes. Quiroga J; Rodríguez-Sanromán JL; Guarner F; Rodríguez Ortigosa C; Aréjola JM; Prieto J J Hepatol; 1991 May; 12(3):302-11. PubMed ID: 1940258 [TBL] [Abstract][Full Text] [Related]
13. Quantitative loss of individual eicosapentaenoyl-relative to arachidonoyl-containing phospholipids in thrombin-stimulated human platelets. Mahadevappa VG; Holub BJ J Lipid Res; 1987 Nov; 28(11):1275-80. PubMed ID: 2828497 [TBL] [Abstract][Full Text] [Related]
14. The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: II. Relationship between cytotoxicity and the cyclooxygenase pathway of arachidonic acid metabolism. Szekeres-Bartho J; Falkay G; Török A; Pacsa AS Am J Reprod Immunol Microbiol; 1985 Sep; 9(1):19-22. PubMed ID: 3931486 [TBL] [Abstract][Full Text] [Related]
15. Optimization of an assay for studying the effects of agents on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in washed human platelets. Dragan YP; Ellis EF Prostaglandins Leukot Essent Fatty Acids; 1990 Feb; 39(2):105-9. PubMed ID: 2111551 [TBL] [Abstract][Full Text] [Related]
16. Arachidonate cannot be released directly from diacyl-sn-glycero-3-phosphocholine in thrombin-stimulated platelets. Colard O; Breton M; Pepin D; Chevy F; Bereziat G; Polonovski J Biochem J; 1989 Apr; 259(2):333-9. PubMed ID: 2497734 [TBL] [Abstract][Full Text] [Related]
17. Involvement of arachidonate metabolism in neurotensin-induced prolactin release in vitro. Canonico PL; Speciale C; Sortino MA; Scapagnini U Am J Physiol; 1985 Sep; 249(3 Pt 1):E257-63. PubMed ID: 3929616 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of the lipoxygenase metabolic pathway of arachidonic acid by the SRS-A antagonist, FPL 55712. Casey FB; Appleby BJ; Buck DC Prostaglandins; 1983 Jan; 25(1):1-11. PubMed ID: 6405452 [TBL] [Abstract][Full Text] [Related]
19. Possible role of phospholipase A2 action and arachidonic acid metabolism in angiotensin II-mediated aldosterone secretion. Kojima I; Kojima K; Rasmussen H Endocrinology; 1985 Sep; 117(3):1057-66. PubMed ID: 3926464 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Salari H; Braquet P; Borgeat P Prostaglandins Leukot Med; 1984 Jan; 13(1):53-60. PubMed ID: 6424136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]